The New York Times

In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side effects.

The term has been popularized on social media to describe numbness and low motivation. Experts offer ways to break out of these feelings.

The shift would mean fewer shots recommended for children. But a Danish health official found the idea baffling, saying the United States was getting “crazier and crazier in public health.”

The companies agreed to sell most of their drugs to Medicaid at the prices they charge in European countries and to sell drugs directly to consumers through a planned TrumpRx website.

Proposed new rules would pull all federal financing from hospitals that continue to provide gender treatments for adolescents.

The American Heart Association report runs contrary to recent studies — and the group’s own guidelines — that found any amount of alcohol to be harmful.

The city and surrounding region have some of the highest levels of flu-like illness in the United States.

For ecologists, the Covid-19 pandemic has presented a remarkable natural experiment in what can happen to wild animals when humans stay home.

Medetomidine, a veterinary sedative mixed into fentanyl, has sent thousands to hospitals, not only for overdose but for life-threatening withdrawal. It is spreading to other cities.

A three-judge panel threw out a lower court’s order, allowing the Trump administration to continue defunding the group and other major abortion providers.

A study of more than 45,000 women found that screening women according to their level of risk was as effective in detecting tumors as the one-size-fits-most screening currently recommended.